Concomitant Surgical Ablation for Treatment of Atrial Fibrillation in Patients Undergoing Minimally Invasive Mitral Valve Surgery: A Single-Center Experience in Vietnam.

Autor: Chuong PTV; Department of Adult Cardiovascular Surgery, University Medical Center, Ho Chi Minh City, Vietnam., Thuan PQ; Department of Adult Cardiovascular Surgery, University Medical Center, Ho Chi Minh City, Vietnam., Thanh VT; Thu Duc City Hospital, Ho Chi Minh City, Vietnam., Dinh NH; Department of Adult Cardiovascular Surgery, University Medical Center, Ho Chi Minh City, Vietnam.; Department of Cardiovascular and Thoracic Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.
Jazyk: angličtina
Zdroj: The Thoracic and cardiovascular surgeon [Thorac Cardiovasc Surg] 2024 Feb 09. Date of Electronic Publication: 2024 Feb 09.
DOI: 10.1055/s-0044-1779622
Abstrakt: Background:  This study presents the early and midterm outcomes of combining atrial fibrillation (AF) treatment with minimally invasive mitral valve surgery (MIMVS) at our center.
Methods:  From January 2017 to June 2022, our center treated a total of 86 patients with both MIMVS and surgical AF ablation. The patient cohort included 62 women (72.1%) and 24 men (27.9%). The average EuroScore II was 2.64 ± 1.49%, and the patients were followed up for an average period of 46.31 ± 9.84 months.
Results:  Postoperatively, 95.3% of patients experienced a change in sinus rhythm, and 86.2% were discharged in sinus rhythm. The hospital's mortality rate was 2.3%, with a late mortality rate of 3.5%. Survival analysis revealed an atrial fibrillation-free 5-year follow-up rate of 59.1 ± 9.1%. The 5-year survival rate was 92.7 ± 3.3%.
Conclusion:  Our 5-year experience demonstrates that the combination of MIMVS and surgical AF ablation can be routinely performed with favorable peri- and postoperative outcomes. This reflects our hospital's culture and guidance on patient selection, particularly when adopting minimally invasive approaches for multiple procedures.
Competing Interests: None declared.
(Thieme. All rights reserved.)
Databáze: MEDLINE